Miller, A. M., Szalontay, L., Bouvier, N., Hill, K., Ahmad, H., Rafailov, J., Lee, A. J., Rodriguez-Sanchez, M. I., Yildirim, O., Patel, A., Bale, T. A., Benhamida, J. K., Benayed, R., Arcila, M. E., Donzelli, M., Dunkel, I. J., Gilheeney, S. W., Khakoo, Y., Kramer, K., … Karajannis, M. A. (2022). Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients. Neuro-Oncology, 24(10), 1763–1772. https://doi.org/10.1093/neuonc/noac035

Ellingson, B. M., Gerstner, E. R., Lassman, A. B., Chung, C., Colman, H., Cole, P. E., Leung, D., Allen, J. E., Ahluwalia, M. S., Boxerman, J., Brown, M., Goldin, J., Nduom, E., Hassan, I., Gilbert, M. R., Mellinghoff, I. K., Weller, M., Chang, S., Arons, D., … Cloughesy, T. F. (2022). Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors. Neuro-Oncology, 24(8), 1219–1229. https://doi.org/10.1093/neuonc/noac086

Zacharoulis, S., Szalontay, L., CreveCoeur, T., Neira, J., Higgins, D., Englander, Z., Spinazzi, E., Sethi, C., Canoll, P., Garvin, J., Zylber, R., Damment, S., Zamoryakhin, D., Maddocks, A., Feldstein, N., & Bruce, J. (2022). DDEL-07. A Phase I study examining the feasibility of intermittent convection-enhanced delivery (CED) of MTX110 for the treatment of children with newly diagnosed diffuse midline gliomas (DMGs). Neuro-Oncology, 24(Supplement_1), i35–i35. https://doi.org/10.1093/neuonc/noac079.128

Minns, H. E., Padilla, O., Wei, H.-J., Webster-Carrion, A., Tazhibi, M., McQuillan, N., Zhang, X., Yeh, R., Zhang, Z., Szalontay, L., Pavisic, J., Garty, G., Garvin, J., Zacharoulis, S., Canoll, P., Vanpouille-Box, C. I., Menon, V., Olah, M., Rabadan, R., … Gartrell, R. D. (2022). DIPG-45. Radiation induces a robust interferon response in Diffuse Midline Glioma (DMG), improving the potential for combination immunotherapy. Neuro-Oncology, 24(Supplement_1), i28–i29. https://doi.org/10.1093/neuonc/noac079.102

Fernández, E. C., Wang, J., Griffin, A., Minns, H., Wei, H.-J., Zhang, X., Szalontay, L., Mundi, P., Wu, C.-C., Gartrell, R., Zacharoulis, S., Califano, A., & Pavisic, J. (2022). DIPG-57. A systems biology approach to defining and targeting master regulator dependencies from bulk and single-Cell RNA-seq in diffuse midline glioma (DMG). Neuro-Oncology, 24(Supplement_1), i31–i32. https://doi.org/10.1093/neuonc/noac079.114

Genecin, I., Fullwood, D., Moisander-Joyce, H., Padilla, O., Minns, H., Garvin, J., Szalontay, L., Wu, C.-C., Kahn, J., & Gartrell, R. D. (2022). EPID-07. Outcome disparities in children, adolescents and young adults with medulloblastoma: A population-based analysis. Neuro-Oncology, 24(Supplement_1), i48–i48. https://doi.org/10.1093/neuonc/noac079.175

Webster Carrion, A., Wei, H.-J., McQuillan, N., Tazhibi, M., Kokossis, D., Berg, X., Minns, H., Zhang, X., Zhang, Z., Wang, J., Fernandez, E. C., Jan, C.-I., Padilla, O., Gartrell, R. D., Becher, O., Jr, J. H. G., Pavisic, J., Szalontay, L., Konofagou, E. E., … Wu, C.-C. (2022). MODL-24. Focused ultrasound-mediated blood-brain barrier opening and panobinostat in a thalamic syngeneic murine DMG model is feasible and safe. Neuro-Oncology, 24(Supplement_1), i174–i174. https://doi.org/10.1093/neuonc/noac079.647

McQuillan, N., Tazhibi, M., Wei, H.-J., Pouliopoulos, A., Bendau, E., Carrion, A. W., Berg, A., Kokossis, D., Zhang, X., Zhang, Z., Englander, Z., Yoh, N., Jan, C.-I., Gartrell, R. D., Garvin, J., Szalontay, L., Konofagou, E., Zacharoulis, S., & Wu, C.-C. (2022). MODL-25. Radiation and focused ultrasound–mediated blood–brain barrier opening for DMG: safety and feasibility of combinatorial therapy. Neuro-Oncology, 24(Supplement_1), i174–i174. https://doi.org/10.1093/neuonc/noac079.648

Hill, K., Miller, A. M., Li, B. K., Bouvier, N., Li, S., Alano, T., Doe-Tetteh, S., Huereca, C., DiNapoli, S., Lee, A., Szalontay, L., Riviere-Cazaux, C., Burns, T. C., Haque, S., Bale, T., Benhamida, J., Dogan, S., Vanderbilt, C., Ross, D., … Karajannis, M. (2022). PATH-16. Noninvasive diagnosis of gliomas through CSF cfDNA sequencing in pediatric and adolescent and young adult (AYA) patients. Neuro-Oncology, 24(Supplement_1), i162–i162. https://doi.org/10.1093/neuonc/noac079.600

Trudeau, T., Prince, E., Chatain, O., Chee, K., Jackson, E., Limbrick, D., Naftel, R., Feldstein, N., Grant, G., Ginn, K., Niazi, T., Smith, A., Kilburn, L., Chern, J., Drapeau, A., Lam, S., Johnston, J., Dudley, R., Staulcup, S., & Hankinson, T. (2022). RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response. Neuro-Oncology, 24(Supplement_1), i15–i15. https://doi.org/10.1093/neuonc/noac079.049

Mohile, N. A., Messersmith, H., Gatson, N. T. N., Hottinger, A. F., Lassman, A. B., Morton, J., Ney, D., Nghiemphu, P. L., Olar, A., Olson, J., Perry, J., Portnow, J., Schiff, D., Shannon, A., Shih, H. A., Strowd, R., van den Bent, M., Ziu, M., & Blakeley, J. (2021). Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. Neuro-Oncology, 24(3), 358–383. https://doi.org/10.1093/neuonc/noab279

Petridis, P. D., Horenstein, C. I., Pereira, B., Wu, P. B., Samanamud, J., Marie, T., Boyett, D., Sudhakar, T. D., Sheth, S. A., McKhann, G. M., Sisti, M. B., Bruce, J. N., Canoll, P., & Grinband, J. (2021). BOLD asynchrony elucidates tumor burden in IDH-mutated gliomas. Neuro-Oncology, 24(1), 78–87. https://doi.org/10.1093/neuonc/noab154

Vogelbaum, M. A., Brown, P. D., Messersmith, H., Brastianos, P. K., Burri, S., Cahill, D., Dunn, I. F., Gaspar, L. E., Gatson, N. T. N., Gondi, V., Jordan, J. T., Lassman, A. B., Maues, J., Mohile, N., Redjal, N., Stevens, G., Sulman, E., van den Bent, M., Wallace, H. J., … Schiff, D. (2021). Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. Neuro-Oncology, 24(3), 331–357. https://doi.org/10.1093/neuonc/noab262

Blomquist, M., Noviello, T., D’Angelo, F., Sereduk, C., Rabichow, B., Miller, A., Marin, B.-M., White, F., Sarkaria, J., Lasorella, A., Iavarone, A., Ceccarelli, M., & Tran, N. (2021). CSIG-08. ABT-414 RESISTANT GBM TUMORS HARBOR THE TEK S466I MUTATION AND EXHIBIT INCREASED STEMNESS. Neuro-Oncology, 23(Supplement_6), vi34–vi35. https://doi.org/10.1093/neuonc/noab196.134

Symeonides, S., Evans, J., Arkenau, H.-T., McKean, M., Lakhani, N., Lim, E., Falchook, G., Rotolo, J., Capiaux, G., Michel, R., Kaesshaefer, S., & Bexon, A. (2021). CTNI-49. PHASE 1 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN ß, IN PATIENTS WITH ADVANCED SOLID TUMORS, WITH A PHASE 2 EXPANSION IN RECURRENT GLIOBLASTOMA MULTIFORME. Neuro-Oncology, 23(Supplement_6), vi71–vi71. https://doi.org/10.1093/neuonc/noab196.274

Varn, F., Johnson, K., Wade, T., Malta, T., Sabedot, T., Barthel, F., Kim, H., Ahmed, N., Datta, I., Barnholtz-Sloan, J., Bakas, S., D’Angelo, F., Gan, H., Garofano, L., Huse, J., Khasraw, M., Kocakavuk, E., Migliozzi, S., Ormond, D., … Verhaak, R. (2021). EPCO-09. LONGITUDINAL ANALYSIS OF DIFFUSE GLIOMA REVEALS CELL STATE DYNAMICS AT RECURRENCE ASSOCIATED WITH CHANGES IN GENETICS AND THE MICROENVIRONMENT. Neuro-Oncology, 23(Supplement_6), vi3–vi3. https://doi.org/10.1093/neuonc/noab196.008

Gupta, P., Dang, M., Hao, D. H., Bojja, K., Tran, T. M., Shehwana, H., Kamiya-Matsuoka, C., Li, J., Audia, A., Kassab, C., Ott, M., Gumin, J., Al-enazy, S., Balasubramaniyan, V., DeGroot, J., Lang, F., Iavarone, A., Navin, N. E., Heimberger, A. B., … Bhat, K. (2021). IMMU-43. IMMUNE CONTEXTURE OF ISOCITRATE DEHYDROGENASE STRATIFIED HUMAN GLIOMAS REVEALED BY SINGLE-CELL TRANSCRIPTOMICS AND ACCESSIBLE CHROMATIN. Neuro-Oncology, 23(Supplement_6), vi102–vi102. https://doi.org/10.1093/neuonc/noab196.402

Venkataramani, V., Yang, Y., Schubert, M., Beretta, C., Botz, M., Fankhauser, L., Tetzlaff, S., Wagner, J., Garofano, L., Freudenberg, A., Slowik, M., Tanev, D., Döring, L., Iavarone, A., Wick, W., Kuner, T., & Winkler, F. (2021). TAMI-52. NEURONAL MECHANISMS OF BRAIN TUMOR INVASION. Neuro-Oncology, 23(Supplement_6), vi209–vi209. https://doi.org/10.1093/neuonc/noab196.835

Argenziano, M., Banu, M., Dovas, A., Zhao, W., Furnari, J., Higgins, D., Upadhyayula, P., Mahajan, A., Humala, N., Sims, P., Bruce, J. N., & Canoll, P. (2021). TAMI-57. INDUCTION OF FERROPTOSIS PROMOTES IMMUNOGENIC CELL DEATH AND ACTIVATION OF THE IMMUNE MICROENVIRONMENT IN GLIOMA. Neuro-Oncology, 23(Supplement_6), vi210–vi210. https://doi.org/10.1093/neuonc/noab196.839

Banu, M., Dovas, A., Argenziano, M., Zhao, W., Higgins, D., Upadhyayula, P., Mahajan, A., Humala, N., Nguyen, T., Zandkarimi, F., Siegelin, M. D., Brent, S., Sims, P., Bruce, J. N., & Canoll, P. (2021). TAMI-70. METABOLIC VULNERABILITY TO GPX4 INHIBITION AND FERROPTOSIS OF QUIESCENT ASTROCYTE-LIKE GLIOMA CELL POPULATIONS. Neuro-Oncology, 23(Supplement_6), vi212–vi213. https://doi.org/10.1093/neuonc/noab196.852

Sabedot, T. S., Malta, T. M., Snyder, J., Nelson, K., Wells, M., deCarvalho, A. C., Mukherjee, A., Chitale, D. A., Mosella, M. S., Sokolov, A., Asmaro, K. P., Robin, A., Rosenblum, M. L., Mikkelsen, T., Rock, J., Poisson, L. M., Lee, I., Walbert, T., Kalkanis, S., … Noushmehr, H. (2021). A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, 23(9), 1494–1508. https://doi.org/10.1093/neuonc/noab023

Lee, E. Q., Selig, W., Meehan, C., Bacha, J., Barone, A., Bloomquist, E., Chang, S. M., de Groot, J. F., Galanis, E., Hassan, I., Kalidas, C., Khasraw, M., Kvedar, J. C., Lassman, A. B., Puduvalli, V., Sahebjam, S., Schwamm, L. H., Tamir, S., Welch, M., … Wen, P. Y. (2021). Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. Neuro-Oncology, 23(8), 1252–1260. https://doi.org/10.1093/neuonc/noab082